Knowledge base
Archived articles from Synergus RWE, kept for reference.
7 articles
Unlocking Real-World Evidence utilising lab results – case study in Kidney disease in Denmark
LABKA and RLRR: Denmark’s Rich Laboratory Data Sources Denmark has a long tradition of comprehensive health registries, and the laboratory databases LABKA and RLRR are prime examples. LABKA (the Clinical Laboratory…
Denmark Aims for "Digital First"
Denmark is one of the leading countries in Europe in the utility of digital health as an integral part of healthcare delivery. December 2023, an agreement was established to invest 500 Million DKK in the following…
Teaser about what is possible with Danish RWE studies
Access to rich high-quality data for RWE-studies can provide insights beyond what is typically feasible in traditional clinical trials. Denmark has a rich real-world-data environment that allows for linkage between…
Danish Real World Data sources - National Registries
Denmark provides several national registries and disease / intervention registries. One of the unique benefits that Denmark provides is the speed of access. In best case scenario, data can be provided in 2 months. One…
Combination of app-based data collection linked to rich data-sets provides a unique (largely untapped) gold mine
Many have heard that the Nordic Countries have good opportunities for real world evidence studies. From the activity we can observe, it appears that the opportunity is not fully understood by industry. There is a large…
There is more than one validated RWD data source!?
In a recent tweet from the International Society for Pharmacoepidemiology (@ICPE) it was stated from a company that they had the only validated real-world evidence platform that enables reproducible, transparent safety…
Nordic HTA activity
In the below graphs, you can see the HTA activity in the Nordic countries. Particullary interesting to see the increased used of mini-HTA assessments in Norway and Sweden. HTA Update